Adaptive Biotechnologies Corp. (ADPT)
15.86
+0.09
(+0.57%)
USD |
NASDAQ |
Feb 09, 16:00
15.86
0.00 (0.00%)
Pre-Market: 20:00
Adaptive Biotechnologies EPS Diluted (Quarterly) : -0.0887 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Gilead Sciences, Inc. | 2.434 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Arcellx, Inc. | -0.9858 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.58M |
| Revenue (Quarterly) | 71.68M |
| Total Expenses (Quarterly) | 85.26M |
| Enterprise Value | 2.429B |
| Gross Profit Margin (Quarterly) | 73.98% |
| Profit Margin (Quarterly) | -18.94% |
| Earnings Yield | -2.51% |
| Normalized Earnings Yield | -2.514 |